Screening doesn’t reduce ovarian cancer death

Women screened for ovarian cancer do not have a reduced risk of death compared with women who receive their usual care, a clinical trial of nearly 80,000 women has found. The intervention group underwent a six-year screening process (including ultrasounds for four years), while the other group received their usual care. The intervention group was subject to more invasive medical procedures and associated harms as a result of being screened.

Read more at JAMA